These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 2714145

  • 1. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.
    Schjoldager BT, Mortensen PE, Christiansen J, Orskov C, Holst JJ.
    Dig Dis Sci; 1989 May; 34(5):703-8. PubMed ID: 2714145
    [Abstract] [Full Text] [Related]

  • 2. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
    Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ.
    Dig Dis Sci; 1993 Apr; 38(4):665-73. PubMed ID: 8462365
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2.
    Wøjdemann M, Wettergren A, Hartmann B, Hilsted L, Holst JJ.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2513-7. PubMed ID: 10404829
    [Abstract] [Full Text] [Related]

  • 4. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man.
    Wettergren A, Maina P, Boesby S, Holst JJ.
    Scand J Gastroenterol; 1997 Jun; 32(6):552-5. PubMed ID: 9200286
    [Abstract] [Full Text] [Related]

  • 5. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
    Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, Schmiegel WH.
    Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of human gastric lipase secretion by glucagon-like peptide-1.
    Wøjdemann M, Wettergren A, Sternby B, Holst JJ, Larsen S, Rehfeld JF, Olsen O.
    Dig Dis Sci; 1998 Apr; 43(4):799-805. PubMed ID: 9558037
    [Abstract] [Full Text] [Related]

  • 7. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.
    Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ.
    Metabolism; 1994 Jan; 43(1):104-8. PubMed ID: 8289665
    [Abstract] [Full Text] [Related]

  • 8. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.
    Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773
    [Abstract] [Full Text] [Related]

  • 9. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F, Fehmann HC, Göke R, Göke B.
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [Abstract] [Full Text] [Related]

  • 10. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    Digestion; 1992 Jan; 52(3-4):214-21. PubMed ID: 1459356
    [Abstract] [Full Text] [Related]

  • 11. The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.
    Wettergren A, Wøjdemann M, Meisner S, Stadil F, Holst JJ.
    Gut; 1997 May; 40(5):597-601. PubMed ID: 9203936
    [Abstract] [Full Text] [Related]

  • 12. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
    Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hüfner M, Schmiegel WH.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
    Schirra J, Sturm K, Leicht P, Arnold R, Göke B, Katschinski M.
    J Clin Invest; 1998 Apr 01; 101(7):1421-30. PubMed ID: 9525985
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.
    Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ.
    Scand J Gastroenterol; 1994 Jun 01; 29(6):501-5. PubMed ID: 7915853
    [Abstract] [Full Text] [Related]

  • 17. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.
    Orskov C, Holst JJ, Nielsen OV.
    Endocrinology; 1988 Oct 01; 123(4):2009-13. PubMed ID: 2901341
    [Abstract] [Full Text] [Related]

  • 18. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man.
    Schjoldager BT, Baldissera FG, Mortensen PE, Holst JJ, Christiansen J.
    Eur J Clin Invest; 1988 Oct 01; 18(5):499-503. PubMed ID: 3147901
    [Abstract] [Full Text] [Related]

  • 19. Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans.
    Wettergren A, Pridal L, Wøjdemann M, Holst JJ.
    Regul Pept; 1998 Oct 16; 77(1-3):83-7. PubMed ID: 9809800
    [Abstract] [Full Text] [Related]

  • 20. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA.
    Diabetologia; 1999 Mar 16; 42(3):373-9. PubMed ID: 10096792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.